Señales en vivo de RNXT | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer...

Stats
Volumen de hoy	23 507.00
Volumen promedio	38 611.00
Capitalización de mercado	29.22M
EPS	$0 ( 2024-03-28 )
Próxima fecha de ganancias	( $-0.140 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.230
ATR14	$0.0180 (1.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Gentry Leesa	Buy	190 000	Options
2023-06-01	Gentry Leesa	Sell	62 500	Options
2024-01-19	Gentry Leesa	Sell	60 159	Options
2024-02-09	Kocak Ron	Buy	15 000	Options
2022-08-18	Kocak Ron	Sell	34 390	Options

INSIDER POWER
70.96
Last 81 transactions
Buy: 2 293 038 \| Sell: 2 003 949

RenovoRx, Inc. Correlación

10 Correlaciones Más Positivas
ALTR	0.934
DUOL	0.93
OVLY	0.925
SVFAU	0.921
BIOT	0.92
APXI	0.918
RAM	0.917
ANSS	0.916
LCAA	0.914
OTEC	0.913

10 Correlaciones Más Negativas
CBNK	-0.923
GOOD	-0.917
BWB	-0.916
GSMG	-0.915
ALRS	-0.911
CSSEP	-0.909
AROW	-0.909
GNTY	-0.908
FGBI	-0.906
JAGX	-0.905

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

RenovoRx, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-0.990

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-0.990

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-6 000.00 (0.00 %)
EPS:	$-1.080

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.754

Financial Reports:

No articles found.

RenovoRx, Inc.